AMORLITE
DEAD

Serial Number

74501100

Owner

Fuisz Technologies Ltd.

Attorney

RONALD J. BARON

Filing Date

Mar 16, 1994

Add to watchlist:

No watchlists yet
View on USPTO

AMORLITE Trademark

Serial Number: 74501100 • Registration: 2127509

AMORLITE is a trademark filed by Fuisz Technologies Ltd. on March 16, 1994. The trademark is classified under Class 5 (Pharmaceuticals), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

Fuisz Technologies Ltd. (26 trademarks)

3810 Concorde Parkway
Chantilly, VA 22021

Entity Type: 03

Trademark Details

Filing Date

March 16, 1994

Registration Date

January 6, 1998

Published for Opposition

August 1, 1995

Cancellation Date

October 9, 2004

Goods & Services

sugar and preparations made from confectionery, namely candy, pastry, frozen confections, chocolate-based or custard-based fillings for chocolates, chocolate-based or custard-based fillings for chocolate candies, chocolate-based or custard-based fillings for candy bars, frostings, icings, and fondant

medicinal matrix preparations for human, livestock and domestic animal use, namely antacids, antitussives, antihistamines, decongestants, alkaloids, mineral and nutritional supplements, mineral and nutritional additives, laxatives, vitamins, anti-cholesterolemics, antiarrhythmics, antipyretics, analgesics, appetite suppressants, cough suppressants, cough expectorants, mucolytics, anti-inflammatories, coronary dilators, cerebral dilators, peripheral vasodilators, anti-infectives, psychotropics, antimanics, stimulants for the treatment or stimulation of the cardiac system, cerebral system, central nervous system, genitals, hepatic system, intestinal system, respiratory system, spinal system, stomachic system, topical system, uterine system, and vascular system; sedatives, vasodilators, vasoconstrictors, antibiotics, tranquilizers, antipsychotics, anticoagulants, hypnotics, antiemetics, anti-nauseants, anticonvulsants, hyperglycemics and hypoglycemics, diuretics, antispasmodics, uterine relaxants, anabolics, antiasthmatics, mucolytics, anti-uricemics, antiuremics, antilipemics, pharmaceutical preparations for the treatment of gastrointestinal disorders or conditions, ulcer, diarrhea, anginal disorders or conditions, anxiety, migraine condition, benign or malignant tumors, hypertension, thrombosis, uricacidemia, neuromuscular conditions or disorders, obesity, disorders or conditions affecting the thyroid, pharmaceutical preparations for promoting erythropoiesis

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 9, 2004 C8..
REGISTERED-PRINCIPAL REGISTER
Jan 6, 1998 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 14, 1997 CNPR
NON-FINAL ACTION MAILED
Aug 14, 1997 CNRT
NON-FINAL ACTION MAILED
Dec 30, 1996 CNRT
ASSIGNED TO EXAMINER
Dec 26, 1996 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Dec 19, 1996 SUPC
USE AMENDMENT FILED
Oct 24, 1996 IUAF
SOU EXTENSION 1 GRANTED
Aug 1, 1996 EX1G
SOU EXTENSION 1 FILED
Apr 17, 1996 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Oct 24, 1995 NOAM
PUBLISHED FOR OPPOSITION
Aug 1, 1995 PUBO
NOTICE OF PUBLICATION
Jun 30, 1995 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 1995 CNSA
EXAMINER'S AMENDMENT MAILED
Mar 27, 1995 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 1995 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 1994 CRFA
NON-FINAL ACTION MAILED
Aug 8, 1994 CNRT